Company Overview
About Kenvue
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
Business Model & Competitive Advantage
Kenvue's consumer health brand portfolio model creates competitive advantages through the household name recognition and shelf-space permanence of trusted OTC health brands: Tylenol's #1 position in the US acetaminophen pain relief category (held for decades despite FDA-mandated labeling changes and generic competition) reflects consumer trust in a brand associated with safe, effective fever and pain management for children and adults — with pediatricians recommending Tylenol by brand name to parents, creating a healthcare professional endorsement that private label acetaminophen cannot easily replicate. Band-Aid's adhesive bandage category dominance (Band-Aid accounting for 60%+ of US adhesive bandage sales as a genericized trademark — where "Band-Aid" means "adhesive bandage" in American English — creating the market where being named Band-Aid is itself the competitive advantage) demonstrates how Kenvue's brands have become synonymous with their product categories. Listerine's antiseptic mouthwash positioning (clinical efficacy claims backed by FDA monograph compliance — Listerine is the only mouthwash with FDA-approved oral health claims for gingivitis reduction) sustains premium pricing versus private label mouthwashes in drugstore and grocery OTC aisles.
Competitive Landscape 2025–2026
In 2025, Kenvue competes in over-the-counter consumer health, skin care, and oral care against Haleon (LON: HLN, Advil, Sensodyne, Theraflu, Chapstick — UK consumer health spun off from GSK and Pfizer), Procter & Gamble (NYSE: PG, Crest, Vicks, Metamucil, Pepto-Bismol), and Bayer AG (ETR: BAYN, Claritin, Alka-Seltzer, Aspirin consumer health portfolio) for retail pharmacy shelf space, consumer brand preference in OTC health categories, and digital health commerce channel growth. The talc litigation exposure (Kenvue assumed liability for talc claims related to Johnson's Baby Powder from J&J at the spinoff — ongoing mass litigation alleging talc caused mesothelioma and ovarian cancer) represents the most significant legal risk for Kenvue independent of its operating performance. Neutrogena's competition from affordable Korean beauty (CeraVe, La Roche-Posay, and drugstore skincare brands gaining market share through dermatologist recommendations) challenges Neutrogena's premium dermatologist-recommended skincare positioning. The 2025 strategy focuses on Tylenol and Listerine brand equity reinforcement through digital and TV advertising, Neutrogena skin health positioning differentiation from competitive skincare brands, and talc litigation resolution management.
The Kenvue Story
Founders
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
Kenvue is recognized as a market leader in the Consumer Goods sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $15500M in revenue, Kenvue operates at enterprise scale with proven market validation.
Frequently Asked Questions
AI Visibility Rankings
How Kenvue performs in AI search results
Unlock AI Visibility Tracking for Kenvue
See exactly how Kenvue ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.
Join 1,000+ brands · Free 7-day trial · No credit card required
Not So Random Others
Nescafé
Nescafé is the world's best-selling coffee brand, owned and operated by Nestlé, the Swiss food and beverage giant. Launched on April 1, 1938, Nescafé was developed at the request of the Brazilian gove
Arthur J. Gallagher & Co.
Arthur J. Gallagher & Co. is a Rolling Meadows, Illinois-based global insurance brokerage and risk management company — publicly traded on the New York Stock Exchange (NYSE: AJG) as an S&P 500 Financi
Best Western
Best Western Hotels & Resorts is one of the world's largest hotel chains, operating approximately 4,700 hotels across 100+ countries under a family of brands that spans budget (SureStay), midscale (Be
Tropicana
Tropicana is one of the world's most recognized orange juice brands, offering not-from-concentrate, freshly squeezed, and juice blend products in refrigerated and shelf-stable formats across North Ame
Adobe Creative Cloud
Adobe Creative Cloud is the flagship subscription product line of Adobe Inc. (NASDAQ: ADBE), encompassing over 20 professional creative applications including Photoshop, Illustrator, InDesign, Premier
In-N-Out Burger
In-N-Out Burger is a privately held American regional fast-food chain founded in 1948 by Harry and Esther Snyder in Baldwin Park, California. The company is entirely family-owned, with no franchises,
Compare Kenvue with Competitors
See how Kenvue stacks up against competitors in Consumer Goods with side-by-side revenue, market share, and AI visibility data.
Start ComparisonTrack Kenvue's AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Kenvue. Get alerts when AI recommendations change. See competitive intelligence across all AI platforms.